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Background: Admixture mapping is a powerful approach for identifying genetic variants involved in human
disease that exploits the unique genomic structure in recently admixed populations. To use existing published
panels of ancestry-informative markers (AIMs) for admixture mapping, markers have to be genotyped de novo for
each admixed study sample and samples representing the ancestral parental populations. The increased availability
of dense marker data on commercial chips has made it feasible to develop panels wherein the markers need not
be predetermined.
Results: We developed two panels of AIMs (~2,000 markers each) based on the Affymetrix Genome-Wide Human
SNP Array 6.0 for admixture mapping with African American samples. These two AIM panels had good map power
that was higher than that of a denser panel of ~20,000 random markers as well as other published panels of AIMs.
As a test case, we applied the panels in an admixture mapping study of hypertension in African Americans in the
Washington, D.C. metropolitan area.
Conclusions: Developing marker panels for admixture mapping from existing genome-wide genotype data offers
two major advantages: (1) no de novo genotyping needs to be done, thereby saving costs, and (2) markers can be
filtered for various quality measures and replacement markers (to minimize gaps) can be selected at no additional
cost. Panels of carefully selected AIMs have two major advantages over panels of random markers: (1) the map
power from sparser panels of AIMs is higher than that of ~10-fold denser panels of random markers, and (2)
clusters can be labeled based on information from the parental populations. With current technology, chip-based
genome-wide genotyping is less expensive than genotyping ~20,000 random markers. The major advantage of
using random markers is the absence of ascertainment effects resulting from the process of selecting markers. The
ability to develop marker panels informative for ancestry from SNP chip genotype data provides a fresh
opportunity to conduct admixture mapping for disease genes in admixed populations when genome-wide
association data exist or are planned.
Background
Admixture mapping is an approach for localizing disease
susceptibility loci that attempts to capitalize on the
long-range linkage disequilibrium occurring in popula-
tions formed by recent mixing of ancestral populations
[1-6]. The approach uses samples from recently admixed
populations to detect susceptibility loci at which the risk
alleles have different frequencies in the ancestral paren-
tal populations. Admixture mapping is an economical
and theoretically powerful approach. Compared to link-
age, admixture mapping does not require families and
has more power. Compared to association, admixture
mapping requires ~200-500-fold fewer markers, is not
susceptible to allelic heterogeneity, and can be used
with either case-only or case-control study designs.
Admixture mapping can also be performed with
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traits [1]. Admixture mapping has been performed for
many complex traits which exhibit strong differences in
prevalence across ethnicities, such as end-stage renal
disease [7,8], hypertension [9-11], multiple sclerosis [12],
obesity [13-15], peripheral arterial disease [16], prostate
cancer [17,18], rheumatoid arthritis [19], serum inflam-
matory markers [20], systemic lupus erythematosus [21],
type 2 diabetes [22], and white blood cell count [23].
Several groups have built panels of ancestry-informa-
tive markers (AIMs) based on multiple databases of
human genetic variation [24-27]. Previously, admixture
mapping required the construction of panels of AIMs
based on screening large reference sets of genetic varia-
tion for ancestry-informative markers followed by de
novo genotyping at those preselected markers in the
admixed study sample and the samples representing
the (putative) ancestral parental populations [12,20,
23,26,28,29]. However, given commercially available
high-density marker arrays, it is now possible to con-
struct customized panels from markers already geno-
typed in the admixed study sample(s) [27,30-34].
In this study, we constructed marker panels for
admixture mapping with African American populations,
starting from the Affymetrix Genome-Wide Human
SNP Array 6.0, which probes variation at 909,508 single-
nucleotide polymorphisms (SNPs). Using genome-wide
genotypes in our study sample of African Americans
already experimentally determined for genome-wide
association studies and HapMap data to represent the
presumed ancestral parental populations, we constructed
one panel consisting of SNPs with large differences in
allele frequencies between the ancestral parental popula-
tions and a second panel consisting of SNPs with large
FST values between the ancestral parental populations.
We also constructed a panel consisting of random mar-
kers not selected to be ancestrally informative. Charac-
teristics of these panels, including the number of
markers and information content, are presented. As a
test case, we apply these panels to a study of hyperten-
sion in African Americans.
Methods
Study Population
The admixed population under study comprised partici-
pants in the Howard University Family Study (HUFS)
from the Washington, D.C. metropolitan area [35]. The
first phase of recruitment involved enrolling and exam-
ining a randomly ascertained cohort of African Ameri-
can families with members in multiple generations. To
facilitate nested case-control study designs, additional
unrelated individuals from the same geographic area
were enrolled in a second phase of recruitment. Partici-
pants were not ascertained based on any phenotypes.
Participants were interviewed and measured for various
anthropometric and clinical variables. Blood pressure
was measured in the sitting position using an oscillo-
metric device (Omron Healthcare, Kyoto, Japan). Three
readings were taken with a ten minute interval between
readings. The reported systolic and diastolic blood pres-
sure readings were the average of the second and third
readings. Hypertension case status was defined as systo-
lic blood pressure ≥ 140 mmHg, or diastolic blood pres-
sure ≥ 90 mmHg, or treatment with antihypertensive
medication. We identified a subset of 1,017 unrelated
individuals including 509 hypertensive cases and 508
controls for use in admixture mapping.
Genome-wide genotyping in the HUFS was performed
using the Affymetrix Genome-Wide Human SNP Array
6.0. DNA samples were prepared and hybridized follow-
ing the manufacturer’s instructions [35]. Genotype calls
were made using the Birdseed algorithm, version 2 [36].
We had four inclusion criteria: the individual sample
call rate had to be ≥ 95% (no samples excluded), the
SNP call rate had to be ≥ 95% (41,885 SNPs excluded),
the minor allele frequency had to be ≥ 0.01 (19,154
SNPs excluded), and the p-value for the Hardy-Wein-
b e r g( H W E )t e s to fe q u i l i b r i u mh a dt ob e≥ 1.0×10
-3
(6,317 SNPs excluded). After filtering, 842,074 autoso-
mal and X chromosomal SNPs remained.
HapMap phase III CEU (1,403,896 SNPs and 180 indi-
viduals), YRI (1,484,416 SNPs and 180 individuals), and
ASW (1,536,247 SNPs and 90 individuals) genotype data
were obtained from the International HapMap Project
http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/
2008-07_phaseIII/. We retained unrelated individuals,
leaving 109 CEU individuals, 108 YRI individuals, and
55 ASW individuals. We used the same criteria (sample
call rate > 95%, locus call rate ≥ 95%, minor allele fre-
quency > 0.01, HWE p ≥ 1.0×10
-3) for filtering geno-
types. After filtering, the intersection of the CEU, YRI,
and HUFS data sets included 708,383 SNPs. We used
these contemporary samples of 109 unrelated CEU indi-
viduals and 108 unrelated YRI individuals as proxy sam-
ples for the presumed ancestral parental populations of
our African American sample.
δ and FST Calculations
For a given SNP, δ was calculated as the absolute dif-
f e r e n c ei na l l e l ef r e q u e n c i e si nt h eC E Ua n dY R Id a t a ,
δ =| pCEU - pYRI|. Wright [37] suggested the fixation
index FST to evaluate population differentiation.
We estimated FST between the CEU and YRI samples












Wright [38] suggested qualitative guidelines for the
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Page 2 of 12interpretation of FST: values from 0 to 0.05 indicate lit-
tle population differentiation, values between 0.05 and
0.15 indicate moderate population differentiation,
values between 0.15 and 0.25 indicate large population
differentiation, and values above 0.25 indicate very
large population differentiation.
Genetic Map of SNPs
The Rutgers Combined Linkage-Physical Map of the
Human Genome was used to locate markers on the
genetic map (in cM) given positions on the physical
map (in bp). The positions of SNPs on the genetic map
were obtained using a web-based application http://
integrin.ucd.ie/cgi-bin/rs2cm.cgi.
Selection of Ancestry-Informative Markers from HapMap
Data
We followed a six-step process to select AIMs. First, we
selected SNPs for which the minor allele frequency was
≥ 0.01 in both ancestry populations (CEU and YRI). Sec-
ond, we filtered for SNPs for which δ ≥ 0.6 between
CEU and YRI. Third, we divided each chromosome into
consecutive, non-overlapping bins of size 1 Mb and
sorted the SNPs within each bin in descending order
according to the δ values. Fourth, for each chromosome,
we estimated pairwise correlations between the top-
ranked SNPs across the bins. Fifth, for each pair of
SNPs, if r
2 ≥ 0 . 4i ne i t h e rt h eC E Uo rY R Is a m p l e ,w e
discarded the SNP with the smaller δ value from its bin
and promoted all remaining SNPs in that bin. If δ values
were equal (to the fourth decimal place), we discarded
the distal SNP. We iterated steps 4-5 until r
2 <0 . 4i n
either of the CEU or YRI sample for all pairs of top-
ranked SNPs per bin. The resulting panel comprised
2,076 AIMs. We repeated this entire process based on
FST ≥ 0.4, yielding a second panel consisting of 1,923
AIMs. Given δ = 0.6, the allowable values of FST range
from δ
2 =0 . 3 6t o 
 2 0 429 − = . [39]. Similarly, given FST




FST + = . to FST = 0 632 . [39]. These calcula-
tions show the comparability of the two thresholds.
Information Content and Map Power
We calculated the Shannon information content (SIC),
defined as
SIC a a a a a a a a ii ii i jj jj j
=− + + − + +











in which a00 =( 1-m)×pYRI, a01 = m × pCEU, a10 =
(1 - m)×( 1-pYRI), a11 = m ×( 1-pCEU), and m is the
proportion of European ancestry.
For a locus i and individual j, Xij was defined as the
entropy of the locus-specific ancestry estimate and Gj
was defined as the entropy of the genome-wide ancestry
estimate. The relative power at locus i was defined as
rX i j G j i
jj
=− ∑∑ 1/ .I fXij = Gj for all j,t h e nri =0
and there is no additional information about local
ancestry beyond information about genome-wide ances-
try. If Xij =0f o ra l lj,t h e nrj = 1 and there is perfect
information for local ancestry [31]. The statistic ri and
the average of ri across loci, ravg, were estimated using
ANCESTRYMAP [3]. Relative to a study with perfect
information about local ancestry (ravg =1 ) ,1 / ravg times
as many samples must be genotyped to achieve compar-
able power [31].
Estimation of Individual Admixture and Population
Structure
W eu s e dt h ev a r i a n c ei n f l a t i o nf a c t o r( V I F )t op r u n e





R in which R2
∧ is the multiple correla-
tion coefficient. A VIF of 1 implies that the index
SNP is completely independent of all other SNPs.
Starting from a common set of SNPs passing quality
control among the HapMap CEU, HapMap YRI, and
HUFS data sets, we used LD-based pruning (VIF 1.1,
window size 50 SNPs, window slide of 5 SNPs) to
generate a set of 74,546 SNPs with minimal LD
between the markers. We then randomly selected
one-third of the SNPs to obtain a random marker
panel (21 k random panel) that had 10-fold greater
marker density than the AIMs panels. We also gener-
ated an additional panel (2 k random panel) by ran-
domly sub-sampling 10% of the 21 k random panel to
match the marker density of the AIMs panels. We
examined clustering using a parametric approach
implemented in STRUCTURE [40] and a nonpara-
metric approach implemented in AWclust [41]. Ana-
lysis was performed in STRUCTURE without any
prior population assignment and was performed ten
times for each number of clusters (K), with 10,000
burn-in steps and a run length of 10,000 steps under
the admixture model. We recorded the log likelihood
of each analysis conditional on K estimated by
STRUCTURE. Compared with this parametric
approach, the nonparametric approach in AWclust
[41] uses allele-sharing distance (ASD) and Ward’s
minimum variance algorithm to cluster the indivi-
duals in the ASD matrix. AWclust does not assume
Hardy-Weinberg equilibrium or linkage equilibrium
and does not require allele frequency estimates. We
varied K from one to six in both programs.
Application of the panels to a study of hypertension
Two statistics were used to test for the presence of dis-
ease loci using ANCESTYMAP [3]. One was the locus-
genome statistic, which compared the admixture
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among cases only. The locus-genome statistic was tested
via a likelihood-ratio statistic, i.e., the likelihood of a
locus being a disease locus to the likelihood of the locus
not being a disease locus. The LOD score was defined
as the likelihood-ratio test statistic divided by 2ln(10).
The genome-wide significance threshold of the LOD
score was set at 2 [3]. The other statistic was the case-
control statistic, which compared cases with controls at
every point in the genome, testing for differences in
ancestry estimates. A deviation from the genome-wide
average of one parental population ancestry seen in
cases but not in controls provided evidence of a disease
locus. The case-control statistic followed the standard
normal distribution under the null hypothesis that a
locus was not a disease locus. The genome-wide signifi-
cance threshold of the z-statistic was set at ± 4.2 for the
two panels of AIMs and ± 4.7 for the panel based on
random markers. We specified in the disease model that
the relative risk for hypertensive heart disease among
African Americans was 2.80 compared to European
Americans [26].
Results
Marker Panels for Admixture Mapping in African
Americans
The distribution of SNPs across the AIMs panels (one
based on δ contained 2,076 AIMs (Additional file 1), the
other based on FST contained 1,923 AIMs (Additional
file 2)) and two random marker panels (21 k random
marker panel and 2 k random marker panel, Additional
file 3) are shown in Table 1. The panels covered all 22
autosomes and the X chromosome (Table 1). All marker
panels showed lower heterozygosities in the parental
samples than in the admixed sample, with the two
panels of AIMs showing ascertainment effects of lower
heterozygosities in the parental samples and higher het-
erozygosity in the admixed sample (Table 2). Scatter
plots of allele frequencies for AIMs showed clear differ-
entiation of the two parental populations (Figure 1), as
d i dt h eS T R U C T U R Ep l o ta s s u m i n gK = 2 populations
(Figure 2) and the AWclust plot (Additional file 4).
Excluding centromeres, the average inter-marker dis-
tance was 1.33 cM for the panel based on δ, 1.43 cM for
the panel based on FST, 0.124 cM for the panel based on
Table 1 Distribution of markers
HapMap SNPs included
in GWAS data
Number of markers (start position - end position in Mb)
Chromosome Panel based on δ Panel based on FST Panel based on 21 k
random markers
Panel based on 2 k
random markers
1 55,147 167 (0.8-247.2) 150 (0.8-247.2) 1,734 (0.7-247.1) 171 (2.3-245.7)
2 58,091 184 (0.6-241.7) 177 (0.6-241.7) 1,545 (0.4-242.7) 155 (0.6-241.0)
3 47,963 139 (0.3-199.1) 132 (0.3-199.1) 1,376 (0.3-198.9) 137 (0.4-198.2)
4 43,771 139 (2.2-190.9) 131 (2.2-190.9) 1,327 (0.3-191.0) 143 (0.7-187.2)
5 44,805 115 (1.0-180.6) 106 (1.0-180.6) 1,303 (0.5-180.6) 133 (0.5-180.4)
6 44,882 107 (0.9-170.4) 95 (0.9-170.4) 1,182 (0.1-170.8) 146 (0.2-170.8)
7 37,440 112 (1.2-158.5) 104 (1.2-158.5) 1,126 (0.2-158.5) 98 (1.3-157.5)
8 38,149 115 (0.3-144.9) 107 (0.3-144.9) 1,006 (0.4-146.1) 97 (1.1-143.1)
9 32,770 82 (0.3-140.1) 76 (0.3-140.1) 1,003 (0.2-140.2) 91 (0.9-140.2)
10 37,715 105 (0.7-135.2) 98 (0.7-135.2) 1,042 (0.7-135.3) 107 (1.3-130.6)
11 34,812 92 (2.6-132.9) 84 (2.6-132.9) 965 (0.2-134.5) 93 (1.9-134.2)
12 33,366 87 (0.3-131.1) 75 (0.3-131.1) 1,072 (0.1-132.1) 101 (1.8-129.5)
13 26,886 63 (18.9-113.8) 61 (18.9-113.8) 824 (18.2-114.1) 87 (18.2-112.3)
14 22,056 68 (19.9-106.3) 61 (19.9-106.3) 742 (19.5-105.1) 70 (19.5-102.9)
15 20,351 66 (20.6-99.6) 59 (20.6-99.6) 726 (20.3-99.9) 69 (20.4-99.2)
16 21,527 60 (0.9-88.7) 58 (0.9-86.1) 776 (0.1-88.6) 66 (3.0-87.6)
17 16,077 53 (0.1-74.5) 49 (0.1-74.5) 708 (0.1-78.6) 76 (0.8-76.0)
18 20,776 49 (1.0-75.7) 46 (1.0-75.7) 722 (0.3-76.1) 72 (0.3-75.5)
19 9,560 38 (1.6-62.2) 36 (1.6-63.0) 488 (0.3-63.7) 42 (1.0-63.7)
20 18,133 52 (0.9-61.2) 50 (0.9-61.2) 648 (0.0-62.4) 60 (0.3-61.5)
21 9,948 26 (15.9-45.3) 24 (15.9-45.3) 344 (13.3-46.8) 40 (14.8-46.7)
22 8,831 24 (17.0-48.7) 21 (17.0-48.7) 415 (15.3-49.5) 46 (15.3-49.5)
X 25,327 133 (0.8-154.1) 123 (2.6-154.1) 563 (0.1-154.7) 69 (0.2-152.6)
Total 708,383 2,076 1,923 21,637 2,169
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on 2 k random markers (Additional file 5). The average
values of δ, FST, and SIC were 0.715, 0.519, and 0.300
for the δ panel, 0.708, 0.531, and 0.308 for the FST
panel, 0.142, 0.049, and 0.026 for the 21 k random mar-
ker panel, and 0.143, 0.050, and 0.026 for the 2 k ran-
dom marker panel, respectively (Additional file 6).
The two panels of AIMs shared 1,745 markers. The
remaining markers (331 in the panel based on δ,1 7 8
in the panel based on FST) showed no significant dif-
ference in Shannon information content (SIC)( t-test,
p = 0.10). The δ and FST values in the two panels were
highly positively correlated (r =0 . 9 2 ,p < 0.0001). The
δ in the panel based on δ was significantly higher than
Table 2 Average heterozygosities
Panel based on δ Panel based on FST Panel based on 21 k random
markers












CEU 0.242 (0.240) 0.230 (0.229) 0.278 (0.276) 0.278 (0.277)
HUFS 0.385 (0.389) 0.383 (0.387) 0.281 (0.280) 0.283 (0.283)
YRI 0.229 (0.228) 0.226 (0.225) 0.267 (0.266) 0.271 (0.269)
Figure 1 HapMap phase III CEU and YRI allele frequencies.T o pl e f t )P a n e lb a s e do nδ. Top right) Panel based on FST. Bottom left) Panel
based on 21 k random markers. Bottom right) Panel based on 2 k random markers.
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Similarly, FST in the panel based on FST was
significantly higher than FST in the panel based on δ
(p < 0.0001).
Sample Characteristics
The genome-wide average FST between HUFS and YRI
was 0.0295, indicating little population differentiation.
The genome-wide average FST was 0.0656 between
HUFS and CEU and 0.0753 between CEU and YRI, both
indicating moderate population differentiation. As
expected, these results indicated that our admixed
HUFS sample was more similar to YRI than CEU, i.e.,
the proportion of African ancestry exceeded the propor-
tion of European ancestry. Similarly, principal coordi-
nate analysis showed that the HUFS sample was
intermediate between the two ancestral parental popula-
tions and on average closer to YRI than CEU (Addi-
tional file 4). The estimated proportions of African
ancestry in the HUFS sample using ANCESTRYMAP
were 0.81 ± 0.11 and 0.84 ± 0.08 for the autosomes and
the X chromosome, respectively.
Admixture Information Content
We evaluated the informativeness of the two panels of
random markers compared to the informativeness of the
two panels of AIMs. The proportions of markers in the
panel of 21 k random markers for which ri ≥ 0.50, ri ≥
0.75, and ri ≥ 0.80 were 96.74%, 7.68%, and 1.20%,
respectively, and the panel had a map power of ravg =
0.65. The proportions of markers in the panel of AIMs
based on δ for which ri ≥ 0.50, ri ≥ 0.75, and ri ≥ 0.80
were 98.82%, 38.86%, and 2.28%, respectively. The panel
of AIMs based on FST yielded values similar to those
from the panel of AIMs based on δ values. The map
power was ravg = 0.73 for the panels based on δ and FST
(Figures 3 and 4). The proportion of markers in the
panel based on 2 k random markers for which ri ≥ 0.50,
ri ≥ 0.75, and ri ≥ 0.80 were 0.19%, 0%, and 0%, respec-
tively, and the panel had a map power of ravg =0 . 1 3
(Figures 3 and 4). These estimates indicate that the two
panels of AIMs extracted more ancestry information
than a 10-fold denser panel of random markers
and much more than the 2 k random marker panel.
Using the ravg statistic, one would need to study
Figure 2 Summary plots from STRUCTURE analysis of individual admixture proportions in HUFS, CEU, and YRI, conditional on K =2
populations. From top to bottom, admixture proportions using the panels based on δ, FST, 2 k random markers, and 21 k random markers.
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Page 6 of 121.37 (= 1/0.73), 1.37 (= 1/0.73), 1.54 (= 1/0.65), and 7.69
(= 1/0.13) times as many samples to maintain power to
detect disease genes as would be necessary if one had
full ancestry information, using the panels based on δ,
FST, 21 k random markers, and 2 k random markers,
respectively.
We constructed panels conditional on approximate
linkage equilibrium over 1 Mb bins. Our iterative prun-
ing procedure was designed to avoid gaps in coverage
and to eliminate background linkage disequilibrium. To
compare our panels with previously published panels,
we obtained two panels of AIMs developed for African
Americans by Tian et al. [28]. From their panel of 4,222
AIMs, 682 AIMs were in common with the CEU, YRI,
Figure 3 Map power. Blue represents ri for the panel of 21 k random markers (ravg = 0.65) and red represents ri for the compared panel. Top)
Panel based on δ (ravg = 0.73). Middle) Panel based on FST (ravg = 0.73). Bottom) Panel based on 2 k random markers (ravg = 0.13).
Figure 4 Percentage of markers with threshold values of ri.
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control. Similarly, 321 AIMs from their panel of 2,000
AIMs were in common with the CEU, YRI, and HUFS
data sets and all 321 AIMs passed quality control. As a
result of the substantial reduction in marker density, the
map power was reduced for both panels of Tian et al.
using our HUFS data set (Table 3). The substantial
reduction in marker density occurred because the panels
of Tian et al. were developed independently of the Affy-
metrix chip we used for genotyping our sample and
there was little overlap in the SNPs in their panels and
on the chip. To investigate if this limitation also applied
to another African American data set, we obtained the
HapMap phase III ASW data. In the ASW data set,
~50% of the AIMs in either panel of Tian et al.w e r e
present, compared to > 98% of the AIMs from our
panels, whereas almost every AIM present in the data
passed quality control (Table 4). These comparisons
highlight the advantage of being able to customize a
panel using preexisting GWAS genotypes, especially for
filling in gaps to improve coverage.
Application of the Admixture Panels
As an example of applying our newly developed panels,
we investigated hypertension in the HUFS. The relative
risk for hypertensive heart disease among African Amer-
icans was 2.80 compared to European Americans [26].
Averaged genome-wide, the individual proportion of
European ancestry was 0.192 ± 0.098, 0.193 ± 0.098, and
0.264 ± 0.106 among normotensive subjects and 0.196 ±
0.119, 0.196 ± 0.119, and 0.268 ± 0.109 among hyper-
tensive subjects, for the panels based on δ, FST, and 21 k
random markers, respectively. Although this result sug-
gests that most of the differential risk in hypertension is
p r o b a b l yn o te x p l a i n a b l eb yg e n e t i c s ,i td o e sn o tp r e -
clude specific loci from significantly contributing to dif-
ferential risk. Assuming the hybrid isolation model, i.e.,
a single generation of admixture with no subsequent
gene flow, the estimated number of generations since
the original admixture event was 7.44 ± 3.35, 7.33 ±
3.01, and 8.65 ± 5.31 for the panels based on δ, FST, and
21 k random markers, respectively.
We performed admixture mapping using both the
locus-genome and case-control statistics for hyperten-
sion in the HUFS data. No marker reached genome-
wide significance for hypertension case/control status
using ANCESTRYMAP (Figure 5). Using a pairwise
score test for markers shared between the two AIM
panels, no significant difference was found between the
panels (p = 0.8616 for the locus-genome statistics, p =
0.3087 for the case-control statistics). Similarly, using a
t-test for AIMs not shared between the two panels, no
significant difference was found between the panels (p =
0.6099 for the locus-genome statistics, p = 0.5607 for
the case-control statistics).
Discussion
In this study, we constructed panels of markers with
variable informativeness for ancestry in admixed African
Americans. We had previously genotyped our sample
using the Affymetrix Genome-Wide Human SNP Array
6.0 for genome-wide association studies. Repurposing
markers for admixture mapping eliminates the need for
de novo genotyping. After linkage disequilibrium-based
pruning, we constructed a set of 2,076 uncorrelated
markers with large differences in allele frequencies and
another set of 1,923 uncorrelated markers with large FST
values. Using these ancestry-informative markers, we
estimated that the proportion of European ancestry in
our sample of 1,017 unrelated African Americans from
Table 3 Comparison of map power for different panels using HUFS
Panel (# of AIMs) # of AIMs used (% Passed QC)
1 Map power
2 Reference
Based on δ (2,076) 1,943 (100%) 0.73 This manuscript
Based on FST (1,923) 1,800 (100%) 0.73 This manuscript
21 k random markers (21,637) 21,074 (100%) 0.65 This manuscript
2 k random markers (2,169) 2,100 (100%) 0.13 This manuscript
Tian 2000 (2,000) 321 (100%) 0.37 [28]
Tian 4222 (4,222) 682 (100%) 0.56 [28]
1 We compared the panels using all autosomal AIMs with quality control criteria locus call rate ≥ 95%, minor allele frequency > 0.01, and HWE p ≥ 1.0×10
-3.
2 Map power (ravg) based on 1,017 individuals in the HUFS data set.
Table 4 Percentages of markers passing quality control
for different panels using the HapMap ASW sample
Panel (# of AIMs) # in ASW (% passed QC) * Reference
Based on δ (2,076) 2,058 (100%) This manuscript
Based on FST (1,923) 1,907 (100%) This manuscript
21 k random markers
(21,637)
21,235 (99.97%) This manuscript
2 k random markers
(2,169)
2,130 (99.95%) This manuscript
Tian 2000 AIMs (2,000) 1,022 (100%) [28]
Tian 4222 AIMs (4,222) 2,125 (100%) [28]
* AIMs in ASW HapMap data set and passing quality control for the different
panels (locus call rate ≥ 95%, minor allele frequency > 0.01, and HWE p ≥
1.0×10
-3).
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Page 8 of 12Washington, D.C. was 0.19 ± 0.11 for both panels, com-
parable to an estimated proportion of 0.21 ± 0.11 in a
sample of 442 African Americans with multiple sclerosis
and 276 controls [3]. Using a set of 21 k random mar-
kers (i.e., not ascertained to be informative for ancestry)
in our study yielded a slightly higher estimate of admix-
ture proportions (0.266 ± 0.108). Although it is possible
to perform genome-wide admixture mapping using
panels of markers not preselected to be informative for
ancestry [30], our results confirm that a few thousand
AIMs can be used to estimate admixture proportions as
efficiently as 10-fold more random markers.
Admixed populations most commonly used in admix-
ture mapping to date involve those formed by recent
admixture between groups originating from different
continents as a result of European maritime expansion
during the past few hundred years [4]. The number of
generations since the original admixture event based on
our sample of African Americans was estimated at 7.44 ±
3.35 and 7.33 ± 3.01 generations for the panels based on
δ and FST, respectively. This estimate is similar to pre-
vious estimates of 6.0 ± 1.6 [3], 6.3 ± 1.1 [26], and 7 [42].
Thus, these estimates are stable across different marker
panels and different samples of African Americans.
The power of admixture mapping is affected by the
information content of the marker map, the sample size,
and admixture proportions. We estimated that both
AIM panels had an average map power of 0.73 ± 0.08,
which is similar to 0.71 ± 0.09 for a previously con-
structed panel of 2,154 AIMs in African Americans [26].
Figure 5 Admixture mapping statistics scores for hypertension. A. Locus-genome statistics for hypertension in the HUFS. Top) Panel based
on δ. Middle) Panel based on FST. Bottom) Panel based on 21 k random markers. B. Case-control statistics for hypertension in the HUFS. Top)
Panel based on δ. Middle) Panel based on FST. Bottom) Panel based on 21 k random markers.
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Page 9 of 12The two panels had higher map power than the panel of
21 k random markers, which had an average map power
of 0.65 ± 0.08. For the locus-genome statistic, a sample
size of 500 cases provides 70% power to detect a locus
conferring 1.7-fold increased risk due to ancestry [3].
Our study sample size of 509 cases and 508 controls
was underpowered for loci conferring 1.5-fold or less
risk due to ancestry. Although the power of admixture
mapping decreases in populations with a much larger
contribution from only one parental population [26], the
map power is fairly constant for values of admixture
proportion from 10% to 90% [3]. Our estimated values
of 19% European ancestry and 81% African ancestry
both fall within this range.
Conclusions
We constructed two panels of AIMs for admixture map-
ping in African Americans from experimentally deter-
mined genotypes using the Affymetrix Genome-Wide
Human SNP Array 6.0. We constructed the panels con-
ditional on linkage equilibrium over 1 Mb bins. Our
iterative pruning procedure was designed to avoid gaps
in coverage and to eliminate background linkage dise-
quilibrium. Given the mathematical relationship between
δ and FST, we recommend both panels of AIMs equally.
Developing marker panels for admixture mapping
from existing genotype data derived from commercial
high density SNP chips offers two major advantages. (1)
No de novo genotyping needs to be done, thereby saving
costs. (2) Markers can be filtered for various quality
measures and replacement markers (to minimize gaps)
can be selected at no additional cost. For our African
American sample, we took advantage of preexisting
HapMap genotypes for the CEU and YRI samples, but
appropriate parental populations may not have already
been sampled for some admixed populations. We found
that the map power for sparser panels of AIMs is higher
than for denser panels of 21 k random markers. Histori-
cally, the number of AIMs in an admixture panel
reflected the trade-off between maximizing genomic
coverage and minimizing genotyping costs. Currently,
custom genotyping a panel of ~2,000 AIMs is less
expensive than chip-based genome-wide genotyping.
However, chip-based genome-wide genotyping is cur-
rently less expensive than custom genotyping a panel of
~20,000 random markers. Presumed parental popula-
tions are necessary to characterize AIMs. In contrast,
parental populations are not needed to characterize ran-
dom markers prior to estimating admixture proportions.
Apart from needing many more random markers com-
pared to AIMs, the major disadvantage of using a panel
of random markers without parental populations or
external reference samples is the inability to label
clusters. Taken together, the ability to develop dense
panels of markers from commercial chips provides a
fresh opportunity to conduct admixture mapping for
disease genes in admixed populations.
Additional material
Additional file 1: Markers in the panel based on δ. δ, FST, and SIC
values for AIMS in the panel based on δ.
Additional file 2: Markers in the panel based on FST. δ, FST, and SIC
values for AIMS in the panel based on FST.
Additional file 3: Markers in the 2 k and 21 k random marker
panels. δ, FST, and SIC values for AIMS in the panel based on 2 k and 21
k random marker panels.
Additional file 4: Multidimensional scaling plot. Top four dimensions
from multidimensional scaling plot showing HUFS in blue circles, CEU in
red squares, and YRI in green diamonds.
Additional file 5: Inter-marker genetic distances (excluding
centromeres). Average inter-marker distances in the panels based on δ,
FST, 2 k, and 21 k random marker.
Additional file 6: Distributions of δ, FST, and SIC for the AIMs
panels. Genome-wide distributions of δ, FST, and SIC values for AIMS. Red
represents values from the panel based on δ, blue represents values from
the panel based on FST, and dark green represents values from the panel
of 21 k random markers. Top) δ values. Middle) FST values. Bottom) SIC
values.
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